Cide-a and Cide-c are induced in the progression of hepatic steatosis and inhibited by eicosapentaenoic acid

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 83, Issue 2, 2010, Pages 75-81

  Jinno, Yasutaka ^a   Nakakuki, Masanori ^a   Sato, Ayumi ^a   Kawano, Hiroyuki ^a   Notsu, Tatsuto ^a   Mizuguchi, Kiyoshi ^a   Shimano, Hitoshi ^b  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cide a; Cide c; EPA; SREBP 1; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; CELL DEATH INDUCING DNA FRAGMENTATION FACTOR ALPHA LIKE EFFECTOR PROTEIN A; CELL DEATH INDUCING DNA FRAGMENTATION FACTOR ALPHA LIKE EFFECTOR PROTEIN C; ICOSAPENTAENOIC ACID; MESSENGER RNA; REGULATOR PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FATTY LIVER; GENE ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; RAT;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; DIET; DIETARY FATS; DISEASE MODELS, ANIMAL; EICOSAPENTAENOIC ACID; FATTY LIVER; GENE EXPRESSION REGULATION; LIVER; MALE; MICE; PROMOTER REGIONS, GENETIC; PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUCROSE; SWEETENING AGENTS;

MURINAE;

EID: 77955432767     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.05.002     Document Type: Article

References (32)

1. Inohara N., Koseki T., Chen S., Wu X., Nunez G. CIDE, a novel family of cell death activators with homology to the 45kDa subunit of the DNA fragmentation factor. Embo J. 1998, 17:2526-2533.
2. Kim J.Y., Liu K., Zhou S., Tillison K., Wu Y., Smas C.M. Assessment of fat-specific protein 27 in the adipocyte lineage suggests a dual role for FSP27 in adipocyte metabolism and cell death. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E654-E667.
3. Puri V., Konda S., Ranjit S., Aouadi M., Chawla A., Chouinard M., Chakladar A., Czech M.P. Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J. Biol. Chem. 2007, 282:34213-34218.
4. Keller P., Petrie J.T., De Rose P., Gerin I., Wright W.S., Chiang S.H., Nielsen A.R., Fischer C.P., Pedersen B.K., MacDougald O.A. Fat-specific protein 27 regulates storage of triacylglycerol. J. Biol. Chem. 2008, 283:14355-14365.
5. Nishino N., Tamori Y., Tateya S., Kawaguchi T., Shibakusa T., Mizunoya W., Inoue K., Kitazawa R., Kitazawa S., Matsuki Y., Hiramatsu R., Masubuchi S., Omachi A., Kimura K., Saito M., Amo T., Ohta S., Yamaguchi T., Osumi T., Cheng J., Fujimoto T., Nakao H., Nakao K., Aiba A., Okamura H., Fushiki T., Kasuga M. FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J. Clin. Invest. 2008, 118:2808-2821.
6. Puri V., Ranjit S., Konda S., Nicoloro S.M., Straubhaar J., Chawla A., Chouinard M., Lin C., Burkart A., Corvera S., Perugini R.A., Czech M.P. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc. Natl. Acad. Sci. USA 2008, 105:7833-7838.
7. Hallberg M., Morganstein D.L., Kiskinis E., Shah K., Kralli A., Dilworth S.M., White R., Parker M.G., Christian M. A functional interaction between RIP140 and PGC-1alpha regulates the expression of the lipid droplet protein CIDEA. Mol. Cell Biol. 2008, 28:6785-6795.
8. Zhou Z., Yon Toh S., Chen Z., Guo K., Ng C.P., Ponniah S., Lin S.C., Hong W., Li P. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat. Genet. 2003, 35:49-56.
9. Matsusue K., Kusakabe T., Noguchi T., Takiguchi S., Suzuki T., Yamano S., Gonzalez F.J. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab. 2008, 7:302-311.
10. Gong J., Sun Z., Li P. CIDE proteins and metabolic disorders. Curr. Opin. Lipidol. 2009, 20:121-126.
11. Rubio-Cabezas O., Puri V., Murano I., Saudek V., Semple R.K., Dash S., Hyden C.S., Bottomley W., Vigouroux C., Magre J., Raymond-Barker P., Murgatroyd P.R., Chawla A., Skepper J.N., Chatterjee V.K., Suliman S., Patch A.M., Agarwal A.K., Garg A., Barroso I., Cinti S., Czech M.P., Argente J., O'Rahilly S., Savage D.B. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol. Med. 2009, 1:280-287.
12. Mozaffarian D., Lemaitre R.N., Kuller L.H., Burke G.L., Tracy R.P., Siscovick D.S. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the cardiovascular health study. Circulation 2003, 107:1372-1377.
13. Nozaki S., Matsuzawa Y., Hirano K., Sakai N., Kubo M., Tarui S. Effects of purified eicosapentaenoic acid ethyl ester on plasma lipoproteins in primary hypercholesterolemia. Int. J. Vitam. Nutr. Res. 1992, 62:256-260.
14. Sato M., Katsuki Y., Fukuhara K., Kawano H., Mizota M., Hamada Y., Kunihiro Y. Effects of highly purified ethyl all-cis-5,8,11,14,17-icosapentaenoate (EPA-E) on rabbit platelets. Biol. Pharm. Bull 1993, 16:362-367.
15. Tamura Y., Hirai A., Terano T., Takenaga M., Saitoh H., Tahara K., Yoshida S. Clinical and epidemiological studies of eicosapentaenoic acid (EPA) in Japan. Prog. Lipid. Res. 1986, 25:461-466.
16. Arita M., Yoshida M., Hong S., Tjonahen E., Glickman J.N., Petasis N.A., Blumberg R.S., Serhan C.N. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA 2005, 102:7671-7676.
17. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 2001, 276:16683-16689.
18. Matsumoto M., Sata M., Fukuda D., Tanaka K., Soma M., Hirata Y., Nagai R. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Atherosclerosis 2008, 197:524-533.
19. Mita T., Watada H., Ogihara T., Nomiyama T., Ogawa O., Kinoshita J., Shimizu T., Hirose T., Tanaka Y., Kawamori R. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis 2007, 191:162-167.
20. Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Saito Y., Ishikawa Y., Oikawa S., Sasaki J., Hishida H., Itakura H., Kita T., Kitabatake A., Nakaya N., Sakata T., Shimada K., Shirato K. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
21. Yahagi N., Shimano H., Hasty A.H., Amemiya-Kudo M., Okazaki H., Tamura Y., Iizuka Y., Shionoiri F., Ohashi K., Osuga J., Harada K., Gotoda T., Nagai R., Ishibashi S., Yamada N. A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J. Biol. Chem. 1999, 274:35840-35844.
22. Harris W.S., Miller M., Tighe A.P., Davidson M.H., Schaefer E.J. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008, 197:12-24.
23. Sekiya M., Yahagi N., Matsuzaka T., Najima Y., Nakakuki M., Nagai R., Ishibashi S., Osuga J., Yamada N., Shimano H. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003, 38:1529-1539.
24. Ishii H., Horie Y., Ohshima S., Anezaki Y., Kinoshita N., Dohmen T., Kataoka E., Sato W., Goto T., Sasaki J., Sasaki T., Watanabe S., Suzuki A., Ohnishi H. Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice. J. Hepatol. 2009, 50:562-571.
25. Tanaka N., Sano K., Horiuchi A., Tanaka E., Kiyosawa K., Aoyama T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2008, 42:413-418.
26. Viswakarma N., Yu S., Naik S., Kashireddy P., Matsumoto K., Sarkar J., Surapureddi S., Jia Y., Rao M.S., Reddy J.K. Transcriptional regulation of Cidea, mitochondrial cell death-inducing DNA fragmentation factor alpha-like effector A, in mouse liver by peroxisome proliferator-activated receptor alpha and gamma. J. Biol. Chem. 2007, 282:18613-18624.
27. Danesch U., Hoeck W., Ringold G.M. Cloning and transcriptional regulation of a novel adipocyte-specific gene, FSP27. CAAT-enhancer-binding protein (C/EBP) and C/EBP-like proteins interact with sequences required for differentiation-dependent expression. J. Biol. Chem. 1992, 267:7185-7193.
28. Kelder B., Boyce K., Kriete A., Clark R., Berryman D.E., Nagatomi S., List E.O., Braughler M., Kopchick J.J. CIDE-A is expressed in liver of old mice and in type 2 diabetic mouse liver exhibiting steatosis. Comp. Hepatol. 2007, 6:4.
29. Forman B.M., Chen J., Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA 1997, 94:4312-4317.
30. Willson T.M., Brown P.J., Sternbach D.D., Henke B.R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 2000, 43:527-550.
31. Marion-Letellier R., Butler M., Dechelotte P., Playford R.J., Ghosh S. Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells-potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation. Am. J. Clin. Nutr. 2008, 87:939-948.
32. Hannah V.C., Ou J., Luong A., Goldstein J.L., Brown M.S. Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J. Biol. Chem. 2001, 276:4365-4372.